Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 2
2015 2
2016 1
2017 1
2018 3
2019 2
2020 1
2021 1
2022 1
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC.
Zhou C, Solomon B, Loong HH, Park K, Pérol M, Arriola E, Novello S, Han B, Zhou J, Ardizzoni A, Mak MP, Santini FC, Elamin YY, Drilon A, Wolf J, Payakachat N, Uh MK, Rajakumar D, Han H, Puri T, Soldatenkova V, Lin AB, Lin BK, Goto K; LIBRETTO-431 Trial Investigators. Zhou C, et al. N Engl J Med. 2023 Nov 16;389(20):1839-1850. doi: 10.1056/NEJMoa2309457. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870973 Clinical Trial.
Estimating the impact of COVID-19-induced coagulopathy.
Subramaniam A, Alamgeer M. Subramaniam A, et al. Among authors: alamgeer m. Ann Acad Med Singap. 2021 Apr;50(4):294-296. doi: 10.47102/annals-acadmedsg.2021113. Ann Acad Med Singap. 2021. PMID: 33990816 Free article. No abstract available.
Novel therapeutic targets in non-small cell lung cancer.
Alamgeer M, Ganju V, Watkins DN. Alamgeer M, et al. Curr Opin Pharmacol. 2013 Jun;13(3):394-401. doi: 10.1016/j.coph.2013.03.010. Epub 2013 Apr 20. Curr Opin Pharmacol. 2013. PMID: 23608109 Review.
The Evolution of Therapies in Non-Small Cell Lung Cancer.
Boolell V, Alamgeer M, Watkins DN, Ganju V. Boolell V, et al. Among authors: alamgeer m. Cancers (Basel). 2015 Sep 9;7(3):1815-46. doi: 10.3390/cancers7030864. Cancers (Basel). 2015. PMID: 26371045 Free PMC article. Review.
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.
McLean LS, Lim AM, Bressel M, Lee J, Ladwa R, Guminski AD, Hughes B, Bowyer S, Briscoe K, Harris S, Kukard C, Zielinski R, Alamgeer M, Carlino M, Mo J, Park JJ, Khattak MA, Day F, Rischin D. McLean LS, et al. Among authors: alamgeer m. Med J Aust. 2024 Feb 5;220(2):80-90. doi: 10.5694/mja2.52199. Epub 2024 Jan 11. Med J Aust. 2024. PMID: 38212673
24 results